Brief: Genocea Reports Qtrly Loss Per Share $0.18

Genocea Biosciences

11/02/2021 14:10

Feb 11 (Reuters) - Genocea Biosciences Inc  GNCA.O :
    * GENOCEA PROVIDES FOURTH QUARTER 2020 CORPORATE UPDATE
    * GEN-011 AND GEN-009 CLINICAL TRIALS CONTINUE TO ADVANCE
    * ANNOUNCING SARS-COV-2 T CELL ANTIGEN DISCOVERY PROGRAM
    * OPERATING PLAN EXTENDS ITS CASH RUNWAY TO END OF 2022.
    * AS OF DECEMBER 31, 2020, CASH AND CASH EQUIVALENTS WERE
$79.8
MILLION COMPARED TO $40.1 MILLION AS OF DECEMBER 31, 2019
    * QTRLY LOSS PER SHARE $0.18
    * Q4 EARNINGS PER SHARE VIEW $-0.21 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX9tGPhj 
Further company coverage:  GNCA.O 

 ((Reuters.Briefs@thomsonreuters.com;))